4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0001209191-23-058666
See Remarks sold 2,376 shares at $12.02 ($28,560)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Scalzo Richard William See Remarks | 2023-12-14 | Sale 10b5-1 | −2,376 | $12.02 | $28,560 | 124,228 | D |
| Open-market sales · 2,376 sh · avg $12.02 · $28,560 | |||||||
Loading xslF345X05/doc4.xml…